tokens: Some of these safety issues are related to the possible long - term effects of chronic hypergastrinemia , which occurs in all patients taking chronic PPIs , others are related to the hypo-/achlorhydria that frequently occurs with chronic PPI treatment , and in others the mechanisms are unclear .